NYSE Listed Company Manual

NYSE to Commence Delisting Proceedings with Respect to the Warrants of Rubicon Technologies, Inc. (RBT WS)

Retrieved on: 
Monday, October 16, 2023
Software, Technology, Professional Services, Finance, NYSE, RBT, Warrant, Bangladesh Securities and Exchange Commission, New York Stock Exchange, Committee, Rubicon Technologies, Exchange, NYSE Listed Company Manual, Security (finance)

Trading in the Company’s Warrants will be suspended immediately.

Key Points: 
  • Trading in the Company’s Warrants will be suspended immediately.
  • Trading in the Company’s Class A common stock — ticker symbol RBT — will be unaffected and will continue on the NYSE.
  • NYSE Regulation has determined that the Company’s Warrants are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.
  • The NYSE will apply to the Securities and Exchange Commission to delist the Warrants upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

NYSE to Commence Delisting Proceedings Against SIGNA Sports United N.V. (SSU)

Retrieved on: 
Wednesday, October 11, 2023
Professional Services, Fintech, Security (finance), NYSE Listed Company Manual, NYSE, Exchange, Committee, Trinidad and Tobago Securities and Exchange Commission

NYSE Regulation has determined that the Company’s Securities are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.

Key Points: 
  • NYSE Regulation has determined that the Company’s Securities are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.
  • The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange.
  • The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20231011565825/en/

Arcus Biosciences Announces New Employment Inducement Grants

Retrieved on: 
Tuesday, October 10, 2023
Biotechnology, Professional Services, Health, General Health, Business, Pharmaceutical, Oncology, Research, Genetics, Science, Clinical Trials, NYSE Listed Company Manual, NYSE, Compensated emancipation, Cancer, Pharmaceutical industry

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted eight new employees options to purchase a total of 34,300 shares of the Company’s common stock at an exercise price per share of $16.41, which was the closing price on October 9, 2023, and restricted stock units to acquire a total of 17,150 shares of the Company’s common stock.

Key Points: 
  • Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted eight new employees options to purchase a total of 34,300 shares of the Company’s common stock at an exercise price per share of $16.41, which was the closing price on October 9, 2023, and restricted stock units to acquire a total of 17,150 shares of the Company’s common stock.
  • The equity awards were granted pursuant to the Company’s 2020 Inducement Plan, which was approved by the Company’s Board of Directors in January 2020 pursuant to the “inducement exception” under NYSE Listed Company Manual Rule 303A.08.

Regis Corporation Receives Continued Listing Notice From NYSE

Retrieved on: 
Friday, October 6, 2023
Cosmetics, Retail, Other Consumer, Women, Teens, Luxury, Other Retail, Bridal, Millennials, Men, Specialty, Family, Lifestyle, Consumer, Fashion, NYSE Listed Company Manual, Corporation, NYSE, Regis Corporation, RGS, Notice, Cryptocurrency

Regis Corporation (NYSE: RGS), a leader in the haircare industry, today announced that it has received written notice (the “Notice”) from the New York Stock Exchange (“NYSE”) that the Company does not presently meet the NYSE’s continued listing standard that requires the Company to maintain a minimum average closing price of $1.00 per share over a period of 30 consecutive trading days.

Key Points: 
  • Regis Corporation (NYSE: RGS), a leader in the haircare industry, today announced that it has received written notice (the “Notice”) from the New York Stock Exchange (“NYSE”) that the Company does not presently meet the NYSE’s continued listing standard that requires the Company to maintain a minimum average closing price of $1.00 per share over a period of 30 consecutive trading days.
  • As set forth in the Notice, as of October 3, 2023, the 30 trading-day average price of the Company’s common stock was $0.92.
  • The NYSE provides for a period of six months following receipt of the Notice for the Company to meet the share price standard and regain compliance for continued listing on the NYSE.
  • The Notice has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on the NYSE, subject to the Company’s compliance with the other continued listing requirements of the NYSE.

Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

Retrieved on: 
Monday, October 2, 2023
Health, Dental, Medical Devices, NYSE Listed Company Manual, Calendar, Common stock, Security (finance), Notice, NYSE, Cryptocurrency

The Notice does not result in the immediate delisting of the Company’s common stock from the NYSE.

Key Points: 
  • The Notice does not result in the immediate delisting of the Company’s common stock from the NYSE.
  • The Company intends to respond to the NYSE within 10 business days of receipt of the Notice of its intent to cure the deficiency.
  • In accordance with NYSE rules, the Company has a period of six months following the receipt of the Notice to regain compliance with the minimum share price requirement.
  • The receipt of the Notice does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

BrightView Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Retrieved on: 
Monday, October 2, 2023
Commercial Building & Real Estate, Construction & Property, Landscape, NYSE Listed Company Manual, PSU, Employment, RSU, BV, NYSE, Brightview, Pharmaceutical industry

The awards were made pursuant to the Company’s previously announced employment letter agreement with Mr. Asplund, and as a material inducement to his joining the Company as its President and Chief Executive Officer.

Key Points: 
  • The awards were made pursuant to the Company’s previously announced employment letter agreement with Mr. Asplund, and as a material inducement to his joining the Company as its President and Chief Executive Officer.
  • The RSUs were granted under the Company’s 2023 Employment Inducement Incentive Award Plan (the “Inducement Plan”).
  • In addition, and pursuant to the employment letter agreement, Mr. Asplund will be granted an inducement award of performance stock units (“PSUs”) under the Inducement Plan with a target award of 250,000 PSUs.
  • Each award was granted as a material inducement to employment in accordance with the NYSE Listed Company Manual Rule 303A.08.

Yelp Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Retrieved on: 
Thursday, September 28, 2023
Apps, Applications, Technology, Marketing, Communications, Internet, Digital Marketing, Social Media, Retail, Online Retail, NYSE Listed Company Manual, Inc., Employment, Professional Football Compensation Committee, Yelp, NYSE, Compensated emancipation, Pharmaceutical industry

Yelp Inc. (NYSE: YELP), the company that connects people with great local businesses, announced that on September 15, 2023, the Compensation Committee of Yelp’s Board of Directors granted inducement restricted stock unit awards covering 15,118 shares of Yelp’s common stock to three new non-executive employees to induce them to accept employment with Yelp.

Key Points: 
  • Yelp Inc. (NYSE: YELP), the company that connects people with great local businesses, announced that on September 15, 2023, the Compensation Committee of Yelp’s Board of Directors granted inducement restricted stock unit awards covering 15,118 shares of Yelp’s common stock to three new non-executive employees to induce them to accept employment with Yelp.
  • Each award was granted under the Yelp Inc. 2023 Inducement Award Plan and vests over a four-year period, subject to continued employment with Yelp through each vesting date.
  • Each award was granted as a material inducement to employment in accordance with the NYSE Listed Company Manual Rule 303A.08.

BowFlex Parent, Nautilus, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule

Retrieved on: 
Wednesday, September 27, 2023
Home Goods, Health, Retail, Fitness & Nutrition, Specialty, NYSE Listed Company Manual, Calendar, Common stock, Security (finance), Notice, NYSE, Nautilus, Inc., Lease, Nautilus

The Notice does not result in the immediate delisting of the Company’s common stock from the NYSE.

Key Points: 
  • The Notice does not result in the immediate delisting of the Company’s common stock from the NYSE.
  • The Company intends to respond to the NYSE within ten business days of receipt of the Notice of its intent to cure the deficiency.
  • In accordance with NYSE rules, Nautilus has a period of six months following the receipt of the Notice to regain compliance with the minimum share price requirement.
  • The receipt of the Notice does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

Arcus Biosciences Announces New Employment Inducement Grants

Retrieved on: 
Tuesday, September 26, 2023
Biotechnology, Pharmaceutical, Health, Oncology, Cancer, NYSE Listed Company Manual, NYSE, Compensated emancipation, Pharmaceutical industry

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted eight new employees options to purchase a total of 33,200 shares of the Company’s common stock at an exercise price per share of $18.66, which was the closing price on September 25, 2023, and restricted stock units to acquire a total of 16,600 shares of the Company’s common stock.

Key Points: 
  • Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted eight new employees options to purchase a total of 33,200 shares of the Company’s common stock at an exercise price per share of $18.66, which was the closing price on September 25, 2023, and restricted stock units to acquire a total of 16,600 shares of the Company’s common stock.
  • The equity awards were granted pursuant to the Company’s 2020 Inducement Plan, which was approved by the Company’s Board of Directors in January 2020 pursuant to the “inducement exception” under NYSE Listed Company Manual Rule 303A.08.

Digital Media Solutions, Inc. Announces Delisting From The New York Stock Exchange

Retrieved on: 
Monday, September 25, 2023
NYSE Listed Company Manual, Advertising, Bangladesh Securities and Exchange Commission, Environment, NYSE, DMS, Security (finance)

CLEARWATER, Fla., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Digital Media Solutions, Inc. (NYSE: DMS) (“DMS” or the “Company”) today announced that it will be delisted from the New York Stock Exchange (the “NYSE”).

Key Points: 
  • CLEARWATER, Fla., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Digital Media Solutions, Inc. (NYSE: DMS) (“DMS” or the “Company”) today announced that it will be delisted from the New York Stock Exchange (the “NYSE”).
  • The Company’s delisting does not affect the Company’s business operations and DMS continues to be focused on its core solutions in service of its advertising clients.
  • The Company will continue to be a Securities and Exchange Commission (“SEC”) reporting company and anticipates that its Class A common stock will begin trading on the over-the-counter markets on September 26, 2023.
  • The Company will consider relisting its Class A common stock on a national securities exchange in the future if the Board of Directors determines that doing so is in the best interest of the Company and its stakeholders.